BioSyent Pharma Launches Cathejell(TM) Jelly 2%; Shipments to Commence May 2012
TORONTO, ONTARIO--(Marketwire -05/09/12)- BioSyent Inc. ("BioSyent") (TSX-V: RX) is pleased to announce that its subsidiary BioSyent Pharma Inc. has launched Cathejell™ Jelly 2% a Sterile Topical Anesthetic for the Canadian healthcare market.
Cathejell™ Jelly 2% is an innovative pharmaceutical product that combines a sterile gel and lidocaine in a unique collapsible applicator syringe which provides a safe and effective solution for patients to ease the discomfort of a range of medical procedures. Cathejell™ Jelly 2% is indicated for surface anesthesia and lubrication for various procedures including: male and female cystoscopies, catheterizations and other endourethral operations; endoscopies, proctoscopies, rectoscopies; and tracheal intubations. Cathejell™ Jelly 2% can also be used for the symptomatic treatment of pain in connection with cystitis and urethritis.
Cathejell™ Jelly 2% was in-licensed by BioSyent Pharma from Pharmazeutische Fabrik MONTAVIT of Absam, Austria (MONTAVIT) and was approved by Health Canada in July 2011 (DIN 02370840). MONTAVIT has been producing and successfully marketing Cathejell™ Jelly 2% for over 40 years. Cathejell™ Jelly 2% is used by healthcare professionals in hospitals and clinics in over 50 countries around the world including England, Germany, France, Switzerland, Sweden, Italy and Spain.
Cathejell™ Jelly 2% has a unique collapsible syringe design with a trauma-free applicator tip that makes it easy to use for healthcare professionals and makes the application of the drug more comfortable for the subject patient.
Cathejell™ Jelly 2% is now available to all hospitals, pharmacies and urology clincs across Canada. Shipments for Cathejell™ Jelly 2% will commence in May 2012. For more information regarding Cathejell™ Jelly 2% visit www.cathejell.ca.
BioSyent Inc. continues to concentrate on its pharmaceutical strategy to source products that have been successfully developed and proven to be safe and effective; manage these products through the regulatory process and product registration (approval); and once approved, market these products in Canada. The Company is focused on medications that occupy a niche in the market, that are unique either due to complexity of manufacture or provide novel technological or therapeutic advantages, or that are backed by strong partners holding intellectual property rights that are defendable. This strategy allows the Company to market these medications as brands owned by, or licensed to, it.
BioSyent Inc. is a publicly traded specialty pharmaceutical company whose wholly owned subsidiary, BioSyent Pharma Inc., sources, acquires or in-licences pharmaceutical products and markets these products in Canada. Wholly owned BioSyent subsidiary Hedley Technologies Ltd. operates the company's legacy business marketing bio and health friendly non-chemical insecticides. BioSyent common shares are listed for trading on the TSX Venture Exchange (TSXV) under the symbol RX.
This press release may contain information or statements that are forward-looking. The contents herein represent our judgment, as at the release date, and are subject to risks and uncertainties that may cause actual results or outcomes to be materially different from the forward-looking information or statements. Potential risks may include, but are not limited to, those associated with clinical trials, product development, future revenue, operations, profitability and obtaining regulatory approvals.
The TSX Venture Exchange assumes no responsibility for the accuracy of this release and neither approves nor disapproves of the same.
Contact:
BioSyent Inc.
Rene C. Goehrum
President and CEO
www.biosyent.com
BioSyent Pharma Launches Cathejell(TM) Jelly 2%; Shipments
Top 10 Most Recent News Articles
Koning Vera Breast CT Gains Canada License for 3D Imaging
Shake-up in Breast Imaging: Koning Vera Gains Canadian Nod Alright, folks, game-changer alert in the breast imaging arena! Koning Health is shaking things up north of the border. The Koning Vera Breast CT system just snagged that coveted Medical Device License (MDL) from Health Canada, clearing the path for Canadian healthcare providers to use this tech marvel. And, let...
Continue Reading
TrewUp Scores Another Inc. Power Partner Award Win
Breaking Through the Noise in B2B Nobody today would be shocked to hear business owners are practically drowning in options when it comes to B2B service providers. But amid this noisy sea, TrewUp has managed to shout louder than the rest by grabbing a 2026 Inc. Power Partner Awards win—for the second year in a row, no less. It seems like they’ve cracked some sort of...
Continue Reading
Winter Prep: Home Safety Vital for Older Adults
Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...
Continue Reading
New CEO at Simpli.fi: Sean McCaffrey Takes Charge
A New Captain at Simpli.fi's Helm In the fast-paced world of digital advertising, Simpli.fi isn't just sitting on the sidelines. They've gone and snagged Sean McCaffrey as their new CEO. Now, for those who remember GSTV's rise to 30,000 locations under McCaffrey, this appointment carries some serious weight. McCaffrey's Track Record: Setting the Pace McCaffrey's no...
Continue Reading
Jackson Hewitt Aims to Recruit 15,000 Seasonal Staff
Revving Up for Tax Season: Jackson Hewitt's Hiring Push When tax season looms, the hustle can't be understated, and Jackson Hewitt is cranking it up by hunting for 15,000 new recruits to tackle this annual financial circus. Starting October 26, this hiring fest is open season across the nation, pulling out all the stops to bolster its workforce. But what does this mean...
Continue Reading
University of Phoenix Lowers Costs for Transfer Students
The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...
Continue Reading
Freight Rebound Sparks Strategic M&A Opportunities
Is the Freight Recovery Here to Stay? Just when you thought trucking might have run out of gas, we're hitting a sharp turn back into growth town. For those of you dropping equity crumbs every which way but loose in the last few years, this freight lull has been brutal—like the hangover from hell. But Brown Gibbons Lang & Company’s fresh report now hints at a brighter...
Continue Reading
AEP Boosts Dividend Amid $78 Billion Expansion Plan
Dividend Hike Sets the Stage Kicking things off with a neat little surprise, American Electric Power (NASDAQ:AEP) has decided to fatten up that dividend check to 97 cents per share—or a solid 2-cent bump. Now, that might not have you dancing on the trading floor, but it sure shows us that AEP's got intentions worth watching. We're looking at a December 10 payday, so...
Continue Reading
DARPA Pumps $10.7M into RxMP's Hemorrhage Control Drug
RxMP Therapeutics Lands a DARPA Deal Would you look at that—RxMP Therapeutics just got handed a load of cash thanks to some good old government backing. Up to $10.7 million from DARPA is no chump change. It's like finding a lifeboat right when you're treading water out there in the big bad sea. This award under the RAPIID program is set to move the needle for RxMP’s...
Continue Reading
IBM Backs Leena AI: Shaping Enterprise Automation
IBM's Strategic Bet on Enterprise Automation Diving into the blazing 2026 market, IBM Ventures has thrown its weight behind Leena AI, an enterprise agentic AI firm that's out to shake things up. You see, the name of the game isn't just flashy AI chatbots anymore. Companies like Leena AI are setting their sights on the back-office grunt work—the lifeblood operations in...
Continue ReadingTop 5 Most Recently Viewed Articles
Terra Balcanica Secures Financing for Growth and Expansion
Terra Balcanica's Successful Financing Initiative With great enthusiasm, Terra Balcanica Resources Corp. (“Terra”) (CNSX: TERA; Frankfurt: UB1) has finalized the first tranche of a significant private placement financing. This strategic move yielded gross proceeds of $129,000 Canadian, showcasing the trust that investors place in the company’s vision and potential....
Continue Reading
Bruce Pon Joins the Foundation for New Creative Economies Board
Bruce Pon Appointed to the Board of FNC? The Foundation for New Creative Economies (FNC?) is excited to announce the appointment of Bruce Pon as a new board member. This significant change occurs as Marjorie Hernandez, a key figure in the LUKSO ecosystem, transitions off the board after her dedicated service. FNC? focuses on fostering innovation and growth within the...
Continue Reading
Fast-Casual Showdown: Sweetgreen and Cava's Q2 Earnings
Sweetgreen vs. Cava: A Tale of Two Earnings Reports The fast-casual restaurant sector is experiencing an intense rivalry as Sweetgreen Inc (SG) and Cava Group Inc (CAVA) share their second quarter financial results. Each company has a distinct narrative, with Sweetgreen facing significant challenges while Cava seems ready to thrive. Sweetgreen's Recent Struggles...
Continue Reading
PainReform Unveils Innovative Ocular Drug-Delivery System
PainReform's Breakthrough in Ocular Drug Delivery PainReform Ltd. (Nasdaq: PRFX) has made exciting strides in the world of ocular therapeutics. The company's recent research and development assessment highlights its innovative LayerBio platform's capacity to deliver drugs effectively without the cumbersome use of eye drops. This technology aims to transform the...
Continue Reading
Park Aerospace Reports Impressive Q3 Fiscal Performance
Overview of Financial Results Park Aerospace Corp. (NYSE: PKE) has recently announced significant financial results for the fiscal year third quarter, showcasing resilience and growth despite various challenges faced in recent times. As a key player in the aerospace materials sector, Park continues to demonstrate its ability to drive sales and maintain profitability....
Continue Reading